Biovie Inc.
BIVI· Nasdaq
BIVIBiovie Inc.
Filed Nov 4, 2022 · 10-Q · 35 days after period end · 0001520138-22-000502
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$10.42M | -$5.54M | $7.33M | -$3.82M |
| EPS Diluted | -$0.38 | -$0.23 | -$7.75 | -$5.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 4, 2022 · 35 d after period end
